-
1
-
-
0001844256
-
Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment
-
Harvey, P. D.; Keefe, R. S. Cognitive impairment in schizophrenia and implication of atypical neuroleptic treatment.CNS Spectr 1997, 2, 41-55. (Pubitemid 127791895)
-
(1997)
CNS Spectrums
, vol.2
, Issue.8
, pp. 41-55
-
-
Harvey, P.D.1
Keefe, R.S.E.2
-
2
-
-
1942536959
-
The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery
-
DOI 10.1016/j.schres.2003.09.011, PII S0920996403002809
-
Keefe, R. S.; Goldberg, T. E.; Harvey, P. D.; Gold, J. M.; Poe, M. P.; Coughenour, L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004, 68, 283-97. (Pubitemid 38526150)
-
(2004)
Schizophrenia Research
, vol.68
, Issue.2-3
, pp. 283-297
-
-
Keefe, R.S.E.1
Goldberg, T.E.2
Harvey, P.D.3
Gold, J.M.4
Poe, M.P.5
Coughenour, L.6
-
3
-
-
0034617355
-
Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study
-
DOI 10.1016/S0920-9964(99)00160-7, PII S0920996499001607
-
Addington, J.; Addington, D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study Schizophr Res 2000, 44, 47-56. (Pubitemid 30365206)
-
(2000)
Schizophrenia Research
, vol.44
, Issue.1
, pp. 47-56
-
-
Addington, J.1
Addington, D.2
-
4
-
-
0029918481
-
What are the functional consequences of neurocognitive deficits in schizophrenia?
-
Green, M. F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996, 153, 321-30. (Pubitemid 26074706)
-
(1996)
American Journal of Psychiatry
, vol.153
, Issue.3
, pp. 321-330
-
-
Green, M.F.1
-
5
-
-
0034029845
-
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the 'right stuff'?
-
Green, M. F.; Kern, R. S.; Braff, D. L.; Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophr. Bull. 2000, 26, 119-36. (Pubitemid 30317696)
-
(2000)
Schizophrenia Bulletin
, vol.26
, Issue.1
, pp. 119-136
-
-
Green, M.F.1
Kern, R.S.2
Braff, D.L.3
Mintz, J.4
-
6
-
-
79952316290
-
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. Ziprasidone
-
Harvey, P. D.; Ogasa, M.; Cucchiaro, J.; Loebel, A.; Keefe, R. S. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.Schizophr Res 2011, 127, 188-94.
-
(2011)
Schizophr Res
, vol.127
, pp. 188-194
-
-
Harvey, P.D.1
Ogasa, M.2
Cucchiaro, J.3
Loebel, A.4
Keefe, R.5
-
7
-
-
21244448316
-
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
-
DOI 10.1017/S146114570500516X
-
Woodward, N. D.; Purdon, S. E.; Meltzer, H. Y.; Zald, D. H. A metaanalysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 2005, 8, 457-72. (Pubitemid 41002500)
-
(2005)
International Journal of Neuropsychopharmacology
, vol.8
, Issue.3
, pp. 457-472
-
-
Woodward, N.D.1
Purdon, S.E.2
Meltzer, H.Y.3
Zald, D.H.4
-
8
-
-
34948816016
-
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: Is it a practice effect?
-
DOI 10.1001/archpsyc.64.10.1115
-
Goldberg, T. E.; Goldman, R. S.; Burdick, K. E.; Malhotra, A. K.; Lencz, T.; Patel, R. C.; Woerner, M. G.; Schooler, N. R.; Kane, J. M.; Robinson, D. G. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry 2007, 64, 1115-22. (Pubitemid 47529336)
-
(2007)
Archives of General Psychiatry
, vol.64
, Issue.10
, pp. 1115-1122
-
-
Goldberg, T.E.1
Goldman, R.S.2
Burdick, K.E.3
Malhotra, A.K.4
Lencz, T.5
Patel, R.C.6
Woerner, M.G.7
Schooler, N.R.8
Kane, J.M.9
Robinson, D.G.10
-
9
-
-
79961166634
-
Comparative pharmacology of antipsychotics possessing combined dopamine d2 and serotonin 5-ht1a receptor properties
-
Newman-Tancredi, A.; Kleven, M. S. Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 2011, 216, 451-73.
-
(2011)
Psychopharmacology
, vol.216
, pp. 451-473
-
-
Newman-Tancredi, A.1
Kleven, M.S.2
-
10
-
-
84877940765
-
Management of cognitive impairments in schizophrenia: The therapeutic role of 5-ht receptors
-
In: Sumiyoshi T editor New York: Nova Science Publishers
-
Ohno, Y.; Tatara, A.; Shimizu, S.; Sasa, M. Management of cognitive impairments in schizophrenia: the therapeutic role of 5-HT receptors. In: Sumiyoshi T, editor. Schizophrenia Research: Recent Advances. New York: Nova Science Publishers; 2012, 321-335.
-
(2012)
Schizophrenia Research: Recent Advances
, pp. 321-335
-
-
Ohno, Y.1
Tatara, A.2
Shimizu, S.3
Sasa, M.4
-
11
-
-
70049094786
-
A possible dose-side effect relationship of antipsychotic drugs: Relevance to cognitive function in schizophrenia
-
Sumiyoshi, T. A possible dose-side effect relationship of antipsychotic drugs: Relevance to cognitive function in schizophrenia. Expert Rev Clin Pharmacol 2008, 1, 791-802.
-
(2008)
Expert Rev Clin Pharmacol
, vol.1
, pp. 791-802
-
-
Sumiyoshi, T.1
-
12
-
-
79952484437
-
The role of serotonin in the nmda receptor antagonist models of psychosis and cognitive impairment
-
Meltzer, H. Y.; Horiguchi, M.; Massey, B. W. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology 2011, 213, 289-305.
-
(2011)
Psychopharmacology
, vol.213
, pp. 289-305
-
-
Meltzer, H.Y.1
Horiguchi, M.2
Massey, B.W.3
-
13
-
-
84877985393
-
Serotonin-1a receptors and cognitive enhancement in schizophrenia; role for brain energy metabolism
-
In: Burne THJ editor InTech
-
Sumiyoshi, T.; Uehara, T. Serotonin-1A receptors and cognitive enhancement in schizophrenia; Role for brain energy metabolism. In: Burne THJ, editor. Schizophrenia in the 21st Century. InTech; 2012 , 127-140.
-
(2012)
Schizophrenia in the 21st Century
, pp. 127-140
-
-
Sumiyoshi, T.1
Uehara, T.2
-
14
-
-
84862703924
-
The role of 5-ht1a receptors in phencyclidine [pcp]-induced novel object recognition deficits in rats
-
Horiguchi, M.; Meltzer, H. Y. The role of 5-HT1A receptors in phencyclidine [PCP]-induced novel object recognition deficits in rats. Psychopharmacology 2012, 221, 205-15.
-
(2012)
Psychopharmacology
, vol.221
, pp. 205-215
-
-
Horiguchi, M.1
Meltzer, H.Y.2
-
15
-
-
84862155436
-
5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons
-
Llado-Pelfort, L.; Santana, N.; Ghisi, V.; Artigas, F.; Celada, P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.Cerebral Cortex 2012, 22, 1487-97.
-
(2012)
Cerebral Cortex
, vol.22
, pp. 1487-1497
-
-
Llado-Pelfort, L.1
Santana, N.2
Ghisi, V.3
Artigas, F.4
Celada, P.5
-
16
-
-
84877980829
-
Gene polymorphism at serotonin 5-ht1a receptors: Moving towards personalized medicine for psychosis and mood deficits?
-
In: Sumiyoshi T editor New York: Nova Science Publishers
-
Newman-Tancredi, A.; Albert, P. R. Gene polymorphism at serotonin 5-HT1A receptors: moving towards personalized medicine for psychosis and mood deficits? In: Sumiyoshi T, editor. Schizophrenia Research: Recent Advances. New York: Nova Science Publishers; 2012, 337-358.
-
(2012)
Schizophrenia Research: Recent Advances
, pp. 337-358
-
-
Newman-Tancredi, A.1
Albert, P.R.2
-
17
-
-
77954102626
-
F15599, a preferential post-synaptic 5-ht1a receptor agonist: Activity in models of cognition in comparison with reference 5-ht1a receptor agonists
-
Depoortere, R.; Auclair, A. L.; Bardin, L.; Colpaert, F. C.; Vacher, B.; Newman-Tancredi, A. F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists. Eur Neuropsychopharmacol 2010, 20, 641-54.
-
(2010)
Eur Neuropsychopharmacol
, vol.20
, pp. 641-654
-
-
Depoortere, R.1
Auclair, A.L.2
Bardin, L.3
Colpaert, F.C.4
Vacher, B.5
Newman-Tancredi, A.6
-
18
-
-
79960501329
-
The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats
-
Horiguchi, M.; Huang, M.; Meltzer, H. Y. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exper Ther 2011, 338, 605-14.
-
(2011)
J Pharmacol Exper Ther
, vol.338
, pp. 605-614
-
-
Horiguchi, M.1
Huang, M.2
Meltzer, H.Y.3
-
19
-
-
82955198514
-
Interaction of mglu/ agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats
-
Horiguchi, M.; Huang, M.; Meltzer, H. Y. Interaction of mGlu/ agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Psychopharmacology. 2011, 217, 13-24.
-
(2011)
Psychopharmacology.
, vol.217
, pp. 13-24
-
-
Horiguchi, M.1
Huang, M.2
Meltzer, H.Y.3
-
20
-
-
79953689886
-
The role of serotonin receptors in the action of atypical antipsychotic drugs
-
Meltzer, H. Y.; Massey, B. W. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 2011, 11, 59-67.
-
(2011)
Curr Opin Pharmacol
, vol.11
, pp. 59-67
-
-
Meltzer, H.Y.1
Massey, B.W.2
-
21
-
-
77953540588
-
Effects of add-on mirtazapine on neurocognition in schizophrenia: A double-blind, randomized, placebo-controlled study
-
Stenberg, J. H.; Terevnikov, V.; Joffe, M.; Tiihonen, J.; Tchoukhine, E.; Burkin, M.; Joffe, G. Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study. Inter J Neuropsychopharmacol 2010, 13, 433-41.
-
(2010)
Inter J Neuropsychopharmacol
, vol.13
, pp. 433-441
-
-
Stenberg, J.H.1
Terevnikov, V.2
Joffe, M.3
Tiihonen, J.4
Tchoukhine, E.5
Burkin, M.6
Joffe, G.7
-
22
-
-
58349098103
-
Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
-
Akhondzadeh, S.; Mohammadi, N.; Noroozian, M.; Karamghadiri, N.; Ghoreishi, A.; Jamshidi, A. H.; Forghani, S. Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial. Schizophrenia Res 2009, 107, 206-12.
-
(2009)
Schizophrenia Res
, vol.107
, pp. 206-212
-
-
Akhondzadeh, S.1
Mohammadi, N.2
Noroozian, M.3
Karamghadiri, N.4
Ghoreishi, A.5
Jamshidi, A.H.6
Forghani, S.7
-
23
-
-
0034810016
-
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment
-
DOI 10.1176/appi.ajp.158.10.1722
-
Sumiyoshi, T.; Matsui, M.; Nohara, S.; Yamashita, I.; Kurachi, M.; Sumiyoshi, C.; Jayathilake, K.; Meltzer, H. Y. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 2001, 158, 1722-5. (Pubitemid 32923670)
-
(2001)
American Journal of Psychiatry
, vol.158
, Issue.10
, pp. 1722-1725
-
-
Sumiyoshi, T.1
Matsui, M.2
Nohara, S.3
Yamashita, I.4
Kurachi, M.5
Sumiyoshi, C.6
Jayathilake, K.7
Meltzer, H.Y.8
-
24
-
-
0035873389
-
1A agonist, on memory function in schizophrenia
-
DOI 10.1016/S0006-3223(00)01025-8, PII S0006322300010258
-
Sumiyoshi, T.; Matsui, M.; Yamashita, I.; Nohara, S.; Kurachi, M.; Uehara, T.; Sumiyoshi, S.; Sumiyoshi, C.; Meltzer, H. Y. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiat 2001, 49, 861-8. (Pubitemid 32436390)
-
(2001)
Biological Psychiatry
, vol.49
, Issue.10
, pp. 861-868
-
-
Sumiyoshi, T.1
Matsui, M.2
Yamashita, I.3
Nohara, S.4
Kurachi, M.5
Uehara, T.6
Sumiyoshi, S.7
Sumiyoshi, C.8
Meltzer, H.Y.9
-
25
-
-
34548189417
-
1A partial agonist, on cognitive function in schizophrenia: A randomized, double-blind, placebo-controlled study
-
DOI 10.1016/j.schres.2007.06.008, PII S0920996407002630
-
Sumiyoshi, T.; Park, S.; Jayathilake, K.; Roy, A.; Ertugrul, A.; Meltzer, H. Y. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res 2007, 95, 158-68. (Pubitemid 47313647)
-
(2007)
Schizophrenia Research
, vol.95
, Issue.1-3
, pp. 158-168
-
-
Sumiyoshi, T.1
Park, S.2
Jayathilake, K.3
Roy, A.4
Ertugrul, A.5
Meltzer, H.Y.6
-
26
-
-
79952639595
-
Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-ht(1a) receptors but not 5-ht(2a) receptors
-
Bortolozzi, A.; Masana, M.; Diaz-Mataix, L.; Cortes, R.; Scorza, M. C.; Gingrich, J. A.; Toth, M.; Artigas, F. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. Int J Neuropsychopharmacol 2010, 13, 1299-314.
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 1299-1314
-
-
Bortolozzi, A.1
Masana, M.2
Diaz-Mataix, L.3
Cortes, R.4
Scorza, M.C.5
Gingrich, J.A.6
Toth, M.7
Artigas, F.8
-
27
-
-
28044469011
-
1A receptors in prefrontal cortex in the modulation of dopaminergic activity: Role in atypical antipsychotic action
-
DOI 10.1523/JNEUROSCI.2999-05.2005
-
Diaz-Mataix, L.; Scorza, M. C.; Bortolozzi, A.; Toth, M.; Celada, P.; Artigas, F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci 2005, 25, 10831-43. (Pubitemid 41692613)
-
(2005)
Journal of Neuroscience
, vol.25
, Issue.47
, pp. 10831-10843
-
-
Diaz-Mataix, L.1
Scorza, M.C.2
Bortolozzi, A.3
Toth, M.4
Celada, P.5
Artigas, F.6
-
28
-
-
0035096016
-
1A receptor activation: A possible mechanism of atypical antipsychotic-induced cortical dopamine release
-
DOI 10.1046/j.1471-4159.2001.00154.x
-
Ichikawa, J.; Ishii, H.; Bonaccorso, S.; Fowler, W. L.; O'Laughlin, I. A.; Meltzer, H. Y. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 2001, 76, 1521-31. (Pubitemid 32198256)
-
(2001)
Journal of Neurochemistry
, vol.76
, Issue.5
, pp. 1521-1531
-
-
Ichikawa, J.1
Ishii, H.2
Bonaccorso, S.3
Fowler, W.L.4
O'Laughlin, I.A.5
Meltzer, H.Y.6
-
29
-
-
77954097572
-
Preferential in vivo action of f15599, a novel 5-ht(1a) receptor agonist, at postsynaptic 5-ht(1a) receptors
-
Llado-Pelfort, L.; Assie, M. B.; Newman-Tancredi, A.; Artigas, F.; Celada, P. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. Br J Pharmacol 2010, 160, 1929-40.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1929-1940
-
-
Llado-Pelfort, L.1
Assie, M.B.2
Newman-Tancredi, A.3
Artigas, F.4
Celada, P.5
-
30
-
-
78649349597
-
Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: A case report
-
Higuchi, Y.; Sumiyoshi, T.; Kawasaki, Y.; Ito, T.; Seo, T.; Suzuki, M. Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report. J Clin Psychopharmacol 2010, 30, 732-4.
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 732-734
-
-
Higuchi, Y.1
Sumiyoshi, T.2
Kawasaki, Y.3
Ito, T.4
Seo, T.5
Suzuki, M.6
-
31
-
-
84877934704
-
Electrophysiological imaging evaluation of schizophrenia and treatment response
-
In: Risner MS editor. Springer
-
Sumiyoshi, T.; Higuchi, Y.; Itoh, T.; Kawasaki, Y. Electrophysiological imaging evaluation of schizophrenia and treatment response. In: Risner MS, editor. Handbook of Schizophrenia Spectrum Disorders,: Springer; 2011.,135-148.
-
(2011)
Handbook of Schizophrenia Spectrum Disorders
, pp. 135-148
-
-
Sumiyoshi, T.1
Higuchi, Y.2
Itoh, T.3
Kawasaki, Y.4
-
32
-
-
0001787597
-
Review of methods for solving the eeg inverse problem
-
Pascual-Marqui, R. D. Review of methods for solving the EEG inverse problem. Int J Bioelectromagnetism 1999, 1, 75-86.
-
(1999)
Int J Bioelectromagnetism
, vol.1
, pp. 75-86
-
-
Pascual-Marqui, R.D.1
-
33
-
-
67349194712
-
Effect of perospirone on p300 electrophysiological activity and social cognition in schizophrenia: A threedimensional analysis with sloreta
-
Sumiyoshi, T.; Higuchi, Y.; Itoh, T.; Matsui, M.; Arai, H.; Suzuki, M.; Kurachi, M.; Sumiyoshi, C.; Kawasaki, Y. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a threedimensional analysis with sloreta. Psychiatry Res 2009, 172, 180-3.
-
(2009)
Psychiatry Res
, vol.172
, pp. 180-183
-
-
Sumiyoshi, T.1
Higuchi, Y.2
Itoh, T.3
Matsui, M.4
Arai, H.5
Suzuki, M.6
Kurachi, M.7
Sumiyoshi, C.8
Kawasaki, Y.9
-
34
-
-
33344461704
-
Perospirone in the treatment of schizophrenia: Effect on verbal memory organization
-
DOI 10.1016/j.pnpbp.2005.10.015, PII S0278584605003246
-
Araki, T.; Yamasue, H.; Sumiyoshi, T.; Kuwabara, H.; Suga, M.; Iwanami, A.; Kato, N.; Kasai, K. Perospirone in the treatment of schizophrenia: effect on verbal memory organization. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30, 204-8. (Pubitemid 43288059)
-
(2006)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.30
, Issue.2
, pp. 204-208
-
-
Araki, T.1
Yamasue, H.2
Sumiyoshi, T.3
Kuwabara, H.4
Suga, M.5
Iwanami, A.6
Kato, N.7
Kasai, K.8
-
35
-
-
34247511054
-
Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia
-
DOI 10.1016/j.pnpbp.2007.02.017, PII S0278584607000760
-
Sumiyoshi, T.; Higuchi, Y.; Matsui, M.; Arai, H.; Takamiya, C.; Meltzer, H. Y.; Kurachi, M. Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31, 965-7. (Pubitemid 46660309)
-
(2007)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.31
, Issue.4
, pp. 965-967
-
-
Sumiyoshi, T.1
Higuchi, Y.2
Matsui, M.3
Arai, H.4
Takamiya, C.5
Meltzer, H.Y.6
Kurachi, M.7
-
36
-
-
33748082340
-
Impairment of event schema in patients with schizophrenia: Examination of script for shopping at supermarket
-
DOI 10.1016/j.psychres.2005.09.006, PII S0165178105002982
-
Matsui, M.; Sumiyoshi, T.; Yuuki, H.; Kato, K.; Kurachi, M. Impairment of event schema in patients with schizophrenia: examination of script for shopping at supermarket. Psychiatry Res 2006, 143, 179-87. (Pubitemid 44301515)
-
(2006)
Psychiatry Research
, vol.143
, Issue.2-3
, pp. 179-187
-
-
Matsui, M.1
Sumiyoshi, T.2
Yuuki, H.3
Kato, K.4
Kurachi, M.5
-
37
-
-
0026098660
-
Increase in serotonin 5ht1a receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia
-
Hashimoto, T.; Nishino, N.; Nakai, H.; Tanaka, C. Increase in serotonin 5HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci. 1991, 48, 355-63.
-
(1991)
Life Sci.
, vol.48
, pp. 355-363
-
-
Hashimoto, T.1
Nishino, N.2
Nakai, H.3
Tanaka, C.4
-
38
-
-
0029670799
-
Serotonin1a receptors are increased in postmortem prefrontal cortex in schizophrenia
-
Sumiyoshi, T.; Stockmeier, C. A.; Overholser, J. C.; Dilley, G. E.; Meltzer, H. Y. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 1996, 708, 209-14.
-
(1996)
Brain Res
, vol.708
, pp. 209-214
-
-
Sumiyoshi, T.1
Stockmeier, C.A.2
Overholser, J.C.3
Dilley, G.E.4
Meltzer, H.Y.5
-
39
-
-
0036270010
-
11C]WAY-100635
-
Tauscher, J.; Kapur, S.; Verhoeff, P. L. G.; Hussey, D. F.; Daskalakis, Z. J.; Tauscher-Wisniewski, S.; Wilson, A. A.; Houle, S.; Kasper, S.; Zipurski, R. B. Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychaitry 2002, 59, 514-20. (Pubitemid 34602933)
-
(2002)
Archives of General Psychiatry
, vol.59
, Issue.6
, pp. 514-520
-
-
Tauscher, J.1
Kapur, S.2
Verhoeff, N.P.L.G.3
Hussey, D.F.4
Daskalakis, Z.J.5
Tauscher-Wisniewski, S.6
Wilson, A.A.7
Houle, S.8
Kasper, S.9
Zipursky, R.B.10
-
40
-
-
84864972683
-
Serotonin 1a receptors in the action of antipsychotic drugs
-
Sumiyoshi, T. Serotonin 1A receptors in the action of antipsychotic drugs. J Psychopharmacol. 2012, 26, 1283-4.
-
(2012)
J Psychopharmacol.
, vol.26
, pp. 1283-1284
-
-
Sumiyoshi, T.1
-
41
-
-
36849046309
-
Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version
-
DOI 10.1111/j.1440-1819.2007.01725.x
-
Kaneda, Y.; Sumiyoshi, T.; Keefe, R.; Ishimoto, Y.; Numata, S.; Ohmori, T. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 2007, 61, 602-9. (Pubitemid 350233482)
-
(2007)
Psychiatry and Clinical Neurosciences
, vol.61
, Issue.6
, pp. 602-609
-
-
Kaneda, Y.1
Sumiyoshi, T.2
Keefe, R.3
Ishimoto, Y.4
Numata, S.5
Ohmori, T.6
|